Release Date: 25/02/15 13:17 Summary: Ceasing to be a substantial holder Price Sensitive: No Download Document 109.17KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%